RxDoctor Payments Data

Todd Parnes, DO

Otolaryngology/Facial Plastic Surgery · Delray Beach, FLNPI 1649250614

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Sanofi at 27.3% of the total. Reporting peaked in 2021 at $1,258 and has fallen 53.0% since, to $591 in 2025.

$4,658in general payments, 2019–2025

Across 131 payments — averaging $35.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Stryker$1K
  • GSK$308
  • Aerin Medical Inc.$308
  • Acclarent, Inc$130
  • plus $394 from 9 others

What the payments were for

  • Travel & lodging$3989%
  • Food & beverage$4,26091%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,658 in reported general payments places this provider in the 80th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$1,012,166
Medicare patients
1,468
Services billed
8,818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide418$17,297
Fluticasone Propionate228$5,701
Pilocarpine Hcl43$2,929
Advair DiskusFluticasone Propion/Salmeterol11$2,871
Montelukast Sodium167$2,154
Pantoprazole Sodium106$2,042
Azelastine Hcl47$1,922
Omeprazole138$1,732
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,496
Tobramycin-DexamethasoneTobramycin/Dexamethasone40$1,493
Methylprednisolone183$1,272
Famotidine66$925
Prednisone42$582
Glycopyrrolate19$526
Gabapentin39$406

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Delray Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →